ArticleScientific reports2025
Photocatalytic degradation of tetracycline from aqueous solution with graphene oxide and hydroxyapatite composites.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Statistical modeling and enhanced performance of a hybrid catalytic photomicroelectrolysis (CPMC) system for tetracycline removal: a Box-Behnken design approach.Scientific reports · 2026Article
- Taguchi optimisation of ZnO and GO-integrated HA nanocomposite with improved antibacterial performance.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing presence of antibiotics such as tetracycline (TC) in aquatic environments has become a critical issue due to their persistence and contribution to antibiotic resistance. In this study, a graphene oxide and hydroxyapatite (GO-HAp) composite was synthesized as photocatalyst, and its performance for visible-light-induced degradation of TC from aqueous solution was evaluated. The incorporation of GO reduced the band gap of HAp from 3.5 eV to 2.8 eV, thereby enhancing the photocatalytic efficiency. The evaluation and optimization of the process parameters including pH, initial TC concentration, and catalyst dosage were carried out using Box-Behnken Design (BBD). Under the optimum conditions (pH 11, 50 mg L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.